{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,9]],"date-time":"2025-10-09T06:41:57Z","timestamp":1759992117508},"reference-count":24,"publisher":"Elsevier BV","issue":"21","license":[{"start":{"date-parts":[[2009,5,1]],"date-time":"2009-05-01T00:00:00Z","timestamp":1241136000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Vaccine"],"published-print":{"date-parts":[[2009,5]]},"DOI":"10.1016\/j.vaccine.2009.03.010","type":"journal-article","created":{"date-parts":[[2009,3,14]],"date-time":"2009-03-14T10:23:01Z","timestamp":1237026181000},"page":"2755-2759","source":"Crossref","is-referenced-by-count":21,"title":["Immune responses in the airways by nasal vaccination with systemic boosting against Pseudomonas aeruginosa in chronic lung disease"],"prefix":"10.1016","volume":"27","author":[{"given":"Stephan","family":"Sorichter","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ulrich","family":"Baumann","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Astrid","family":"Baumgart","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Stephan","family":"Walterspacher","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Bernd-Ulrich","family":"von Specht","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"issue":"11","key":"10.1016\/j.vaccine.2009.03.010_bib1","doi-asserted-by":"crossref","first-page":"1205","DOI":"10.1016\/S0954-6111(03)00231-2","article-title":"Lower respiratory tract infections in chronic obstructive pulmonary disease outpatients with tracheostomy and persistent colonization by P. aeruginosa","volume":"97","author":"Lusuardi","year":"2003","journal-title":"Respir Med"},{"issue":"1","key":"10.1016\/j.vaccine.2009.03.010_bib2","first-page":"24","article-title":"Microbial causes of ventilator-associated pneumonia","volume":"11","author":"Rello","year":"1996","journal-title":"Semin Respir Infect"},{"issue":"11","key":"10.1016\/j.vaccine.2009.03.010_bib3","doi-asserted-by":"crossref","first-page":"1981","DOI":"10.1007\/s00134-003-2008-4","article-title":"A 7-year study of severe hospital-acquired pneumonia requiring ICU admission","volume":"29","author":"Valles","year":"2003","journal-title":"Intensive Care Med"},{"issue":"4","key":"10.1016\/j.vaccine.2009.03.010_bib4","doi-asserted-by":"crossref","first-page":"306","DOI":"10.1097\/01.qco.0000171920.44809.f0","article-title":"Update on Pseudomonas aeruginosa and Acinetobacter baumannii infections in the healthcare setting","volume":"18","author":"Navon-Venezia","year":"2005","journal-title":"Curr Opin Infect Dis"},{"issue":"8","key":"10.1016\/j.vaccine.2009.03.010_bib5","doi-asserted-by":"crossref","first-page":"3382","DOI":"10.1128\/AAC.49.8.3382-3386.2005","article-title":"Hypermutation is a key factor in development of multiple-antimicrobial resistance in Pseudomonas aeruginosa strains causing chronic lung infections","volume":"49","author":"Macia","year":"2005","journal-title":"Antimicrob Agents Chemother"},{"issue":"6","key":"10.1016\/j.vaccine.2009.03.010_bib6","doi-asserted-by":"crossref","first-page":"504","DOI":"10.1097\/01.inf.0000129688.50588.ac","article-title":"Vaccination of cystic fibrosis patients against Pseudomonas aeruginosa reduces the proportion of patients infected and delays time to infection","volume":"23","author":"Lang","year":"2004","journal-title":"Pediatr Infect Dis J"},{"issue":"26","key":"10.1016\/j.vaccine.2009.03.010_bib7","doi-asserted-by":"crossref","first-page":"11020","DOI":"10.1073\/pnas.0702403104","article-title":"A double-blind randomized placebo-controlled phase III study of a Pseudomonas aeruginosa flagella vaccine in cystic fibrosis patients","volume":"104","author":"Doring","year":"2007","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"3","key":"10.1016\/j.vaccine.2009.03.010_bib8","doi-asserted-by":"crossref","first-page":"141","DOI":"10.1016\/S0167-5699(98)01413-3","article-title":"Regional specialization in the mucosal immune system: what happens in the microcompartments?","volume":"20","author":"Brandtzaeg","year":"1999","journal-title":"Immunol Today"},{"issue":"1","key":"10.1016\/j.vaccine.2009.03.010_bib9","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1078\/1438-4221-00241","article-title":"Role of secretory antibodies in the defence against infections","volume":"293","author":"Brandtzaeg","year":"2003","journal-title":"Int J Med Microbiol"},{"issue":"98","key":"10.1016\/j.vaccine.2009.03.010_bib10","first-page":"262","article-title":"Vaccine strategies against Pseudomonas aeruginosa infection in the lung","author":"Cripps","year":"1997","journal-title":"Behring Inst Mitt"},{"issue":"4 Suppl","key":"10.1016\/j.vaccine.2009.03.010_bib11","doi-asserted-by":"crossref","first-page":"35","DOI":"10.4269\/ajtmh.1999.60.35","article-title":"Strategies for mucosal vaccine development","volume":"60","author":"Boyaka","year":"1999","journal-title":"Am J Trop Med Hyg"},{"issue":"5","key":"10.1016\/j.vaccine.2009.03.010_bib12","doi-asserted-by":"crossref","first-page":"1855","DOI":"10.1128\/IAI.63.5.1855-1862.1995","article-title":"Protection of immunocompromised mice against lethal infection with Pseudomonas aeruginosa by active or passive immunization with recombinant P. aeruginosa outer membrane protein F and outer membrane protein I fusion proteins","volume":"63","author":"von Specht","year":"1995","journal-title":"Infect Immun"},{"issue":"3","key":"10.1016\/j.vaccine.2009.03.010_bib13","doi-asserted-by":"crossref","first-page":"1461","DOI":"10.1128\/IAI.67.3.1461-1470.1999","article-title":"Safety and immunogenicity of a Pseudomonas aeruginosa hybrid outer membrane protein F-I vaccine in human volunteers","volume":"67","author":"Mansouri","year":"1999","journal-title":"Infect Immun"},{"issue":"2-3","key":"10.1016\/j.vaccine.2009.03.010_bib14","doi-asserted-by":"crossref","first-page":"161","DOI":"10.1016\/S0928-8244(03)00072-5","article-title":"Clinical study to assess the immunogenicity and safety of a recombinant Pseudomonas aeruginosa OprF\u2013OprI vaccine in burn patients","volume":"37","author":"Mansouri","year":"2003","journal-title":"FEMS Immunol Med Microbiol"},{"issue":"17\u201319","key":"10.1016\/j.vaccine.2009.03.010_bib15","doi-asserted-by":"crossref","first-page":"2291","DOI":"10.1016\/S0264-410X(00)00550-8","article-title":"Safety and immunogenicity of an intranasal Pseudomonas aeruginosa hybrid outer membrane protein F-I vaccine in human volunteers","volume":"19","author":"Larbig","year":"2001","journal-title":"Vaccine"},{"issue":"2-3","key":"10.1016\/j.vaccine.2009.03.010_bib16","doi-asserted-by":"crossref","first-page":"167","DOI":"10.1016\/S0928-8244(03)00094-4","article-title":"Mucosal vaccination with a recombinant OprF\u2013I vaccine of Pseudomonas aeruginosa in healthy volunteers: comparison of a systemic vs. a mucosal booster schedule","volume":"37","author":"Gocke","year":"2003","journal-title":"FEMS Immunol Med Microbiol"},{"issue":"7","key":"10.1016\/j.vaccine.2009.03.010_bib17","doi-asserted-by":"crossref","first-page":"840","DOI":"10.1016\/j.vaccine.2003.11.029","article-title":"Recombinant OprF\u2013OprI as a vaccine against Pseudomonas aeruginosa infections","volume":"22","author":"Baumann","year":"2004","journal-title":"Vaccine"},{"issue":"5735","key":"10.1016\/j.vaccine.2009.03.010_bib18","doi-asserted-by":"crossref","first-page":"774","DOI":"10.1126\/science.1112422","article-title":"Recognition of host immune activation by Pseudomonas aeruginosa","volume":"309","author":"Wu","year":"2005","journal-title":"Science"},{"issue":"1\u20132","key":"10.1016\/j.vaccine.2009.03.010_bib19","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1016\/S0168-1656(00)00311-4","article-title":"Immunogenic efficacy of differently produced recombinant vaccines candidates against Pseudomonas aeruginosa infections","volume":"83","author":"von Specht","year":"2000","journal-title":"J Biotechnol"},{"issue":"1","key":"10.1016\/j.vaccine.2009.03.010_bib20","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1186\/1465-9921-8-57","article-title":"Assessment of pulmonary antibodies with induced sputum and bronchoalveolar lavage induced by nasal vaccination against Pseudomonas aeruginosa: a clinical phase I\/II study","volume":"8","author":"Baumann","year":"2007","journal-title":"Respir Res"},{"issue":"7","key":"10.1016\/j.vaccine.2009.03.010_bib21","doi-asserted-by":"crossref","first-page":"770","DOI":"10.1016\/S0954-6111(03)00026-X","article-title":"Bacterial infections in patients requiring admission for an acute exacerbation of COPD; a 1-year prospective study","volume":"97","author":"Groenewegen","year":"2003","journal-title":"Respir Med"},{"issue":"1","key":"10.1016\/j.vaccine.2009.03.010_bib22","doi-asserted-by":"crossref","first-page":"22","DOI":"10.1053\/jcan.2003.4","article-title":"Ventilator-associated pneumonia: incidence, risk factors, outcome, and microbiology","volume":"17","author":"Pawar","year":"2003","journal-title":"J Cardiothorac Vasc Anesth"},{"issue":"11","key":"10.1016\/j.vaccine.2009.03.010_bib23","doi-asserted-by":"crossref","first-page":"6546","DOI":"10.1128\/IAI.72.11.6546-6553.2004","article-title":"Enhanced immunogenicity in the murine airway mucosa with an attenuated Salmonella live vaccine expressing OprF\u2013OprI from Pseudomonas aeruginosa","volume":"72","author":"Arnold","year":"2004","journal-title":"Infect Immun"},{"issue":"6179","key":"10.1016\/j.vaccine.2009.03.010_bib24","doi-asserted-by":"crossref","first-page":"255","DOI":"10.1038\/334255a0","article-title":"Regulation of antibody isotype secretion by subsets of antigen-specific helper T cells","volume":"334","author":"Stevens","year":"1988","journal-title":"Nature"}],"container-title":["Vaccine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0264410X09003818?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0264410X09003818?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2020,5,16]],"date-time":"2020-05-16T19:44:25Z","timestamp":1589658265000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0264410X09003818"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2009,5]]},"references-count":24,"journal-issue":{"issue":"21","published-print":{"date-parts":[[2009,5]]}},"alternative-id":["S0264410X09003818"],"URL":"https:\/\/doi.org\/10.1016\/j.vaccine.2009.03.010","relation":{},"ISSN":["0264-410X"],"issn-type":[{"value":"0264-410X","type":"print"}],"subject":[],"published":{"date-parts":[[2009,5]]}}}